Gene · 406941
Papers2,518
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,518
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Applications of Stem Cell-Derived Extracellular Vesicles in Nerve Regeneration. | Int J Mol Sci | 2024 | 38892052 | PubTator, text mining | PubMed |
| Epigenetic alterations in preeclampsia: a focus on microRNA149 and tetrahydrofolate reductase gene polymorphisms in Egyptian women. | Ir J Med Sci | 2024 | 38848035 | PubTator, text mining | PubMed |
| Harnessing tetrahedral framework nucleic acids for enhanced delivery of microRNA-149-3p: A new frontier in oral squamous cell carcinoma therapy. | Cell Prolif | 2024 | 38671577 | PubTator, text mining | PubMed |
| Hub Genes, Possible Pathways and Predicted Drugs in Hereditary Gingival Fibromatosis by Bioinformatics Analysis. | Chin J Dent Res | 2024 | 38546525 | PubTator, text mining | PubMed |
| Hsa_circTCF25 Facilitates Oncogenesis in Gastric Cancer Cells by Modulating miR-149 Expression. | Anticancer Res | 2024 | 38537964 | PubTator, text mining | PubMed |
| The role of mir96 in predicting CTC status and prognostic evaluation in gastric cancer patients. | Cell Mol Biol (Noisy-le-grand) | 2024 | 38430012 | PubTator, text mining | PubMed |
| A review on the role of KCNQ1OT1 lncRNA in human disorders. | Pathol Res Pract | 2024 | 38330620 | PubTator, text mining | PubMed |
| Stage II oesophageal carcinoma: peril in disguise associated with cellular reprogramming and oncogenesis regulated by pseudogenes. | BMC Genomics | 2024 | 38308202 | PubTator, text mining | PubMed |
| Retracted: RNA-Sequence Reveals the Regulatory Mechanism of miR-149 on Osteoblast Skeleton under Mechanical Tension. | Stem Cells Int | 2024 | 38298226 | PubTator, text mining | PubMed |
| Exosomal microRNAs in regulation of tumor cells resistance to apoptosis. | Biochem Biophys Rep | 2024 | 38298209 | PubTator, text mining | PubMed |
| Breaking paradigms: Long non-coding RNAs forming gene fusions with potential implications in cancer. | Genes Dis | 2024 | 38292185 | PubTator, text mining | PubMed |
| CircXRN2 accelerates colorectal cancer progression through regulating miR-149-5p/MACC1 axis and EMT. | Sci Rep | 2024 | 38291092 | PubTator, text mining | PubMed |
| High-Density Lipoproteins at the Interface between the NLRP3 Inflammasome and Myocardial Infarction. | Int J Mol Sci | 2024 | 38279290 | PubTator, text mining | PubMed |
| Interaction between long noncoding RNA and microRNA in lung inflammatory diseases. | Immun Inflamm Dis | 2024 | 38270295 | PubTator, text mining | PubMed |
| HIF-2α/LINC02609/APOL1-mediated lipid storage promotes endoplasmic reticulum homeostasis and regulates tumor progression in clear-cell renal cell carcinoma. | J Exp Clin Cancer Res | 2024 | 38263248 | PubTator, text mining | PubMed |
| Harnessing the Stem Cell Niche in Regenerative Medicine: Innovative Avenue to Combat Neurodegenerative Diseases. | Int J Mol Sci | 2024 | 38256066 | PubTator, text mining | PubMed |
| CircUCK2 promotes hepatocellular carcinoma development by upregulating UCK2 in a mir-149-5p-dependent manner. | Discov Oncol | 2024 | 38245591 | PubTator, text mining | PubMed |
| Advances in artificial intelligence for the diagnosis and treatment of ovarian cancer (Review). | Oncol Rep | 2024 | 38240090 | PubTator, text mining | PubMed |
| CircPOFUT1 fosters colorectal cancer metastasis and chemoresistance via decoying miR-653-5p/E2F7/WDR66 axis and stabilizing BMI1. | iScience | 2024 | 38230259 | PubTator, text mining | PubMed |
| Circular RNAs: Potential biomarkers and therapeutic targets for autoimmune diseases. | Heliyon | 2024 | 38205329 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406941/papers?page=4